
Strides Pharma Science on Tuesday said it has received US health regulator's approval for its generic version of triamcinolone acetonide ointment used for treatment of various skin conditions.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2zKZ5j4
via
IFTTT
0 comments:
Post a Comment